This study examines the association of nine polymorphisms belonging to SLC22A1, SP1, PRPF31, NBEA, SCNN1B, CPA6 and CAPN10 genes with glycaemic response to metformin/SU combination therapy among South African adults with T2DM. This evidence concerns the gene SLC22A1 and type 2 diabetes mellitus.